| SpectraBase Spectrum ID |
J2wQzaILn8P |
| Name |
1-(2-Fluorobenzyl)-4-(3,4-methylenedioxybenzyl)piperazine |
| Classification |
Piperazine designer drug |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
328.158706085 u |
| Formula |
C19H21FN2O2 |
| InChI |
InChI=1S/C19H21FN2O2/c20-17-4-2-1-3-16(17)13-22-9-7-21(8-10-22)12-15-5-6-18-19(11-15)24-14-23-18/h1-6,11H,7-10,12-14H2 |
| InChIKey |
PLKMKTFWFIDGBZ-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
328.387 g/mol |
| Nominal Mass |
328 u |
| Quality |
984 |
| Retention Index |
2521 |
| SMILES |
C1=2C(=CC=C(C2)CN2CCN(CC=3C(=CC=CC3)F)CC2)OCO1 |
| SPLASH |
splash10-0a4r-6900000000-6e22d4858cbd2ca91a81 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
Piperazine,1-(2-fluorobenzyl)-4-(3,4-methylenedioxybenzyl)
1-(1,3-benzodioxol-5-ylmethyl)-4-(2-fluorobenzyl)piperazine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_011260 |
